Examining Peripheral and Tumor Cellular Immunome in Patients With Cancer
Immunotherapies are rapidly being integrated into standard of care (SOC) therapy in conjunction with surgery, chemotherapy, and radiotherapy for many cancers and a large number of clinical studies continue to explore immunotherapy alone and as part of combination therapies in patients with cancer. I...
Main Authors: | Eda K. Holl, Victoria N. Frazier, Karenia Landa, Georgia M. Beasley, E. Shelley Hwang, Smita K. Nair |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-07-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fimmu.2019.01767/full |
Similar Items
-
Antibody reactive immunomes of Ehrlichia chaffeensis and E. canis are diverse and defined by conformational antigenic determinants
by: Tian Luo, et al.
Published: (2024-01-01) -
Circulating immunome fingerprint in eosinophilic esophagitis is associated with clinical response to proton pump inhibitor treatment
by: Lola Ugalde-Triviño, et al.
Published: (2024-04-01) -
Immunomics in Pediatric Rheumatic Diseases
by: Shi Huan Tay, et al.
Published: (2019-05-01) -
Inflammatory Bowel Disease Therapy: Beyond the Immunome
by: Claudio Fiocchi, et al.
Published: (2022-05-01) -
Integration of Immunome With Disease-Gene Network Reveals Common Cellular Mechanisms Between IMIDs and Drug Repurposing Strategies
by: Abhinandan Devaprasad, et al.
Published: (2021-05-01)